CA-I2C
6.4.2022 17:47:05 CEST | Business Wire | Press release
i2c Inc. , a leading provider of digital payment and banking technology, today announced its partnership with PingPong , Hangzhou, China-based fintech unicorn providing business owners with modern, cross-border e-commerce payment solutions.
Leveraging i2c’s agile SaaS platform, PingPong will expand its existing commercial credit offering to new regions, specifically Hong Kong SAR and Europe. The product allows merchants to access instant payouts, as well as transaction fees as low as 1%, versus the 5% fees that have been historically charged to these international merchants.
“We are thrilled to work with such an innovative platform that’s redefining global e-commerce for sellers,” said Aurangzaib Khan, i2c general manager – MEA region. “By providing an all-in-one payments solution to a massive B2B market, with key differentiators like real-time transactions and significantly lower transaction fees, PingPong is breaking down international business barriers and putting sellers’ needs at the forefront.”
“We chose to work with i2c because of their deep global footprint and unmatched experience in digital payments,” said Yu Chen, founder and CEO of PingPong. “The partnership provides best-in-class integrated service to our growing portfolio, and through this collaborative expansion we can now cement PingPong’s mission to redefine the digital payment experience for sellers, entrepreneurs, and business owners worldwide.”
This partnership will allow PingPong to utilize i2c’s Visa and Mastercard certifications to both issue and process cards on the two partner card networks in Hong Kong SAR, and i2c’s Visa certification to issue and process in Europe. The PingPong credit card offers transactions in 15 currencies, featuring real-time direct transfers to suppliers, employees and vendors, while also boasting zero foreign exchange fees within the PingPong virtual wallet.
About PingPong
Founded in 2015, PingPong is a leading technology company built on the global vision that empowers cross-border digital commerce to grow. We are one of the largest payment and digital trade solution providers serving ~1 million global businesses, individuals, large enterprises, and financial institutions. Our advanced technology platform allows business to be done in any market and in any currency across the world. Our one-stop, compliant and comprehensive suite of products include e-commerce payment, B2B trade payment, acquiring service, card issuing, FX management, supply chain finance, VAT tax services, enterprise solutions, business intelligence software and more.
Today, PingPong has accommodated business flows from over 170 countries/regions and onboards customers locally from 43 of them. Our tested and proven global infrastructure has processed over $70 billion transaction volume and connects over 100 international e-commerce marketplaces and ecosystem partners, as well as over 100 international financial institutions including top 8 out of 10 world’s largest commercial banks.
PingPong has established more than 20 global offices and holds relevant payment, forex, financing and internet operation licenses and permits in the world’s largest economies including the U.S., Europe, Greater China, Japan and India.
About i2c Inc.
i2c is a global provider of highly-configurable payment and banking solutions. Using i2c's proprietary "building block" technology, clients can easily create and manage a comprehensive set of solutions for credit, debit, prepaid, lending and more, quickly and cost-effectively. i2c delivers unparalleled flexibility, agility, security and reliability from a single global SaaS platform. Founded in 2001, and headquartered in Silicon Valley, i2c's next-generation technology supports millions of users in more than 200 countries/territories and across all time zones. For more information, visit www.i2cinc.com and follow us at @i2cinc .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005846/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom